The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms-Reference-Cited by-同舟云学术

The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms

Published:2021-07-20 Issue:13 Volume:81 Page:944-955
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Jin RenJie¹^ORCID,Strand Douglas W.²^ORCID,Forbes Connor M.¹^ORCID,Case Thomas¹^ORCID,Cates Justin M. M.³,Liu Qi⁴^ORCID,Ramirez‐Solano Marisol⁴^ORCID,Milne Ginger L.⁵,Sanchez Stephanie⁵^ORCID,Wang Zunyi Y.⁶^ORCID,Bjorling Dale E.⁶^ORCID,Miller Nicole L.¹^ORCID,Matusik Robert J.¹^ORCID

Affiliation:

1. Department of Urology Vanderbilt University Medical Center Nashville Tennessee USA

2. Department of Urology UT Southwestern Dallas Texas USA

3. Department of Pathology, Microbiology and Immunology Vanderbilt University Medical Center Nashville Tennessee USA

4. Department of Biomedical Informatics Vanderbilt University Medical Center Nashville Tennessee USA

5. Division of Clinical Pharmacology, Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

6. Department of Surgical Science, School of Veterinary Medicine University of Wisconsin Madison Wisconsin USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24190

Reference37 articles.

1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

2. The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

3. Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

4. The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy

5. Sildenafil influences lower urinary tract symptoms

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Change in prostate tissue gene expression following finasteride or doxazosin administration in the medical therapy for prostatic symptoms (MTOPS) study;Scientific Reports;2024-08-19

2. Ageratum conyzoides Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia via Inhibiting Proliferation, Inflammation of Prostates, and Induction of Apoptosis in Rats;Nutrients;2024-07-14

3. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance;The Prostate;2024-01-03

4. PTGIS May Be a Predictive Marker for Ovarian Cancer by Regulating Fatty Acid Metabolism;Computational and Mathematical Methods in Medicine;2023-02-02

5. The anti-inflammatory properties of the methanolic extract of Cucumis melo Linn. against prostate enlargement in Wistar rats;Saudi Journal of Biological Sciences;2022-09